Medical Microbiology Testing Technologies Market to Witness a Robust CAGR of 5.4% from 2016 to 2024
Rapid identification of microorganisms in medical microbiology can be of great value for selection of ideal treatments for patients for infections caused by bacteria, viruses, fungus, mycobacterium, and parasites. It enables actual reduction from conventional broad spectrum antimicrobial agents to specific targeted antimicrobial therapy.
View full press release